These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10909423)

  • 1. Anti-sense approach to anticholinesterase therapeutics.
    Soreq H; Seidman S
    Isr Med Assoc J; 2000 Jul; 2 Suppl():81-5. PubMed ID: 10909423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis.
    Brenner T; Hamra-Amitay Y; Evron T; Boneva N; Seidman S; Soreq H
    FASEB J; 2003 Feb; 17(2):214-22. PubMed ID: 12554700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
    Brenner T; Nizri E; Irony-Tur-Sinai M; Hamra-Amitay Y; Wirguin I
    J Neuroimmunol; 2008 Sep; 201-202():121-7. PubMed ID: 18684515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulated-single fiber electromyography monitoring of anti-sense induced changes in experimental autoimmune myasthenia gravis.
    Boneva N; Hamra-Amitay Y; Wirguin I; Brenner T
    Neurosci Res; 2006 May; 55(1):40-4. PubMed ID: 16504322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic function and Alzheimer's disease.
    Giacobini E
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S1-5. PubMed ID: 12973744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.
    Nizri E; Hamra-Amitay Y; Sicsic C; Lavon I; Brenner T
    Neuropharmacology; 2006 Apr; 50(5):540-7. PubMed ID: 16336980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular therapeutics by RNA-targeted suppression of ACHE gene expression.
    Dori A; Soreq H
    Ann N Y Acad Sci; 2006 Oct; 1082():77-90. PubMed ID: 17145929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.
    Volpicelli-Daley LA; Duysen EG; Lockridge O; Levey AI
    Ann Neurol; 2003 Jun; 53(6):788-96. PubMed ID: 12783426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
    Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
    Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity.
    Meshorer E; Erb C; Gazit R; Pavlovsky L; Kaufer D; Friedman A; Glick D; Ben-Arie N; Soreq H
    Science; 2002 Jan; 295(5554):508-12. PubMed ID: 11799248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling.
    Farchi N; Ofek K; Podoly E; Dong H; Xiang YY; Diamant S; Livnah O; Li J; Hochner B; Lu WY; Soreq H
    Neurodegener Dis; 2007; 4(2-3):171-84. PubMed ID: 17596712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system.
    Zivin M; Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):168-73. PubMed ID: 18587286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology.
    Silman I; Sussman JL
    Curr Opin Pharmacol; 2005 Jun; 5(3):293-302. PubMed ID: 15907917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatments for myasthenia: a focus on antisense oligonucleotides.
    Angelini C; Martignago S; Bisciglia M
    Drug Des Devel Ther; 2013; 7():13-7. PubMed ID: 23341732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
    Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
    Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclic inhibitors of AChE acylation and peripheral sites.
    Bolognesi ML; Andrisano V; Bartolini M; Cavalli A; Minarini A; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    Farmaco; 2005; 60(6-7):465-73. PubMed ID: 15878569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development.
    Dori A; Cohen J; Silverman WF; Pollack Y; Soreq H
    Cereb Cortex; 2005 Apr; 15(4):419-30. PubMed ID: 15749986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.